Online information regarding tamoxifen is overall negative, varies considerably in quality, and frequently exceeds the comprehension level of the general public, with higher-quality sources proving the most difficult for readers to understand. A cross-sectional evaluation published in the Journal of Cancer Survivorship demonstrated that higher informational quality on the web positively correlates with greater text complexity, presenting a barrier to informed decision-making for patients seeking guidance on their care.
Tamoxifen represents the first targeted anticancer agent developed for breast cancer and has an established record of reducing both recurrence and mortality.
To capture the content most likely encountered by the public, the investigators utilized Google Trends to identify the top four search terms for tamoxifen between 2020 and 2025. Two independent researchers queried these terms and then re-queried them two weeks later to enhance cross-sectional accuracy, assembling a final sample of fifty-five unique websites that were subsequently categorized according to authorship.
The study evaluated the retrieved websites across four primary dimensions: quality, readability, distractibility, and emotional tone. Quality was appraised using the DISCERN instrument alongside the JAMA benchmark criteria. Readability was calculated across multiple validated metrics, including the Flesch Reading Ease, the Flesch-Kincaid Grade Level, the Coleman-Liau Index, and the SMOG index formula. In addition, distractibility was measured using a validated assessment tool developed by Truumees and colleagues, while website tone was quantified using IBM Watson Natural Language Understanding.
The analysis revealed that journal repositories scored significantly higher in informational quality compared to social media websites (p < 0.05), which registered the lowest quality scores in the cohort. However, average text complexity across the evaluated sites ranged at or above the twelfth-grade reading level. Furthermore, higher quality scores were positively correlated with higher reading grade levels (p < 0.05). Across the differing website authorship categories, the researchers detected no statistically significant differences in either distractibility index measurements or evaluated tones.
Because cancer survivors increasingly turn to the internet for health resources, the research team noted that the observed complexity of high-quality sources poses challenges for patient comprehension and autonomous choice. The authors concluded that clinicians can utilize these findings to better understand the digital landscape patients navigate and to actively guide subsequent clinical conversations regarding tamoxifen therapy.
Subject of Research: Quality, readability, distractibility, and tone of online information regarding tamoxifen
Article Title: Tamoxifen on the web: accessible, but can anyone understand it?
Article References: Eum, J. L., Smilen, S. H., Hannigan, C. M., Pandya, D., Friend, K. E., Boolbol, S. K., & Anderson, C. W. (2026). Tamoxifen on the web: accessible, but can anyone understand it?. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-026-02155-6
Image Credits: AI Generated
DOI: 10.1007/s11764-026-02155-6
Keywords: tamoxifen, breast cancer, cancer survivorship, online health information, health literacy, DISCERN instrument, JAMA benchmark criteria, readability, Flesch Reading Ease, Flesch-Kincaid Grade Level, Coleman-Liau Index, SMOG index, text complexity, IBM Watson Natural Language Understanding, patient nonadherence, distractibility index
News Source: Nathaniel Bowman. (November 12, 2026). High-Quality Online Tamoxifen Information Exceeds Twelfth-Grade Reading Level. Scienmag.



